MiSaver (umbilical cord blood derived nucleated cells)
/ HONYA Medical
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 12, 2026
SEMIAMI: Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II
(clinicaltrials.gov)
- P2 | N=102 | Not yet recruiting | Sponsor: HONYA Medical Co Ltd | Trial completion date: Dec 2026 ➔ Dec 2027 | Initiation date: Oct 2025 ➔ Mar 2026 | Trial primary completion date: Dec 2026 ➔ Dec 2027
Trial completion date • Trial initiation date • Trial primary completion date • Cardiovascular • Myocardial Infarction
August 21, 2025
SEMIAMI: Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II
(clinicaltrials.gov)
- P2 | N=100 | Not yet recruiting | Sponsor: HONYA Medical Co Ltd
New P2 trial • Cardiovascular • Myocardial Infarction
1 to 2
Of
2
Go to page
1